ResMed Inc. (RMD) Q2 2026 Earnings Call Transcript

January 29, 2026 08:23:01 pm

Source: SeekingAlpha

2026-01-29 20:23:01 ET

ResMed Inc. (RMD) Q2 2026 Earnings Call January 29, 2026 4:30 PM EST

Company Participants

Sallilyn Schwartz - Chief Investor Relations Officer
Michael Farrell - CEO & Chairman
Brett Sandercock - Chief Financial Officer
...

For further details see:

Resmed Inc. Chess Depository Interest

-6.3% G/L:

$25.425 Last:

210 Volume:

$27.1336 Open:

Market Cap $40,201,411,540

Float 146,930,660

Insiders Ownership N/A

Institutions 121

Short Percent N/A

Industry Medical Equipment & Supplies

Sector Healthcare

Country US

City San Diego